No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
603 |
4. Check minimum number of eventsNone |
603 |
5. Include endpointsNone |
603 |
6. Filter based on genotype QC (FinnGen only) |
576 |
Control definitions (FinnGen only)
- Control exclude
- AB1_OTHER_BACTERIAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Infection due to other mycobacteria
based on the number of shared cases.
Similar with more cases:
- Other bacterial diseases
- Other bacterial diseases
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4384 | 2364 | 1935 |
| Only index persons | 2970 | 1735 | 1235 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.07 | 0.05 |
| Only index persons | 0.06 | 0.06 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 67.61 | 68.82 | 66.10 |
| Only index persons | 66.78 | 68.03 | 65.03 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 576 | 306 | 270 |
| Unadjusted period prevalence (%) | 0.12 | 0.11 | 0.12 |
| Median age at first event (years) | 66.83 | 65.13 | 68.76 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 603
- Matched controls
- 6030
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
10551.7
307.7
412
*
J47
ICD-10 Finland
Bronchiectasis
45.0
277.4
172
53
UGC12
NOMESCO Finland
Flexible bronchoscopy
15.6
229.9
248
258
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
21.2
221.7
186
124
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
10.5
170.3
248
377
R03BB04
ATC
tiotropium bromide; inhalant
9.3
146.9
231
379
TGC00
NOMESCO Finland
Bronchial lavation
22.4
143.7
111
60
A49.9
ICD-10 Finland
Bacterial infection, unspecified
38.4
136.9
86
26
A31.9
ICD-10 Finland
Mycobacterial infection, unspecified
+∞
130.0
120
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
6.9
124.9
353
1030
J01MA14
ATC
moxifloxacin; systemic
9.4
121.5
173
248
GD1AD
NOMESCO Finland
Thorax CT examination
10.8
108.9
132
153
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
15.4
104.8
97
74
J01MA12
ATC
levofloxacin; systemic
6.0
96.5
241
606
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
5.6
94.9
267
744
R03AK06
ATC
salmeterol and fluticasone; inhalant
6.1
93.6
218
513
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.9
82.6
114
154
R03DA04
ATC
theophylline; systemic, rectal
7.8
76.5
119
184
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
5.7
74.9
174
401
R04.2
ICD-10 Finland
Haemoptysis
10.4
72.5
86
95
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
8.2
71.4
105
152
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.9
69.2
149
319
J45.9
ICD-10 Finland
Asthma, unspecified
4.6
66.7
221
676
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
65.1
413
2001
R03AC12
ATC
salmeterol; inhalant
7.4
62.5
99
155
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
10.3
60.4
71
77
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
9.3
58.2
74
89
A31.89
ICD-10 Finland
Other mycobacterial infections
+∞
56.1
53
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
5.9
54.8
110
218
J45.1
ICD-10 Finland
Nonallergic asthma
6.0
52.8
104
202
H02AB06
ATC
prednisolone; systemic
3.7
52.1
390
2003
R03AC02
ATC
salbutamol; inhalant
3.9
51.6
430
2360
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.6
50.8
394
2057
A31.1
ICD-10 Finland
Cutaneous mycobacterial infection
529.6
50.2
49
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.3
47.5
87
157
R50.9
ICD-10 Finland
Fever, unspecified
4.4
45.7
138
383
H02AB04
ATC
methylprednisolone; systemic
4.0
45.7
162
506
R03DC03
ATC
montelukast; oral
4.0
45.4
162
508
R03BA05
ATC
fluticasone; inhalant
3.7
43.7
179
615
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
9.2
40.5
51
60
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.3
39.8
61
91
R03AK08
ATC
formoterol and beclometasone; inhalant
6.9
39.3
64
102
R03AK03
ATC
[U] fenoterol and ipratropium bromide
5.1
39.3
91
203
XG410
NOMESCO Finland
Flow-volume spirometry
7.0
39.2
63
99
J46
ICD-10 Finland
Status asthmaticus
10.9
39.1
43
42
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.4
38.1
184
696
R03AC03
ATC
terbutaline; inhalant
3.8
37.4
140
449
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
5.4
36.4
78
162
R81
ICPC
Pneumonia
7.2
36.3
56
84
WW200
NOMESCO Finland
Immunization
10.4
36.0
41
42
R03BB01
ATC
ipratropium bromide; inhalant
5.4
35.9
76
156
0310A
ICD-9 Finland
Diseases due to other mycobacteria, Pulmonary
+∞
35.8
34
*
J01FA06
ATC
roxithromycin; oral
2.9
35.5
317
1679
H02AB07
ATC
prednisone; oral
3.6
35.4
145
492
J96.1
ICD-10 Finland
Chronic respiratory failure
8.1
34.4
48
64
A46
ICD-10 Finland
Erysipelas
5.2
33.7
75
161
J01FA09
ATC
clarithromycin; systemic
2.8
31.8
240
1150
R03BA01
ATC
beclometasone; inhalant
3.4
31.1
136
478
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
12.6
30.1
30
25
R03BA02
ATC
budesonide; inhalant
3.1
29.5
156
613
R03AC13
ATC
formoterol; inhalant
4.9
28.5
67
150
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
28.1
144
554
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
81.7
28.0
31
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
6.4
27.2
47
79
J45.8
ICD-10 Finland
Mixed asthma
7.1
27.1
42
63
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.6
26.3
96
299
A41.9
ICD-10 Finland
Sepsis, unspecified
+∞
26.2
25
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
8.3
24.5
33
42
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
23.6
103
358
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
7.9
23.6
33
44
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.8
23.5
77
222
J01AA02
ATC
doxycycline; systemic
3.1
23.5
508
3832
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
22.5
265
1513
R03DC01
ATC
zafirlukast; oral
8.2
21.4
29
37
J45
ICD-10 Finland
Asthma
3.4
21.3
85
279
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.1
21.1
62
165
SPAT1255
SPAT
Intravenous administration of medicine
4.2
20.8
59
153
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.1
20.6
59
154
49300
ICD-8 Finland
Asthma, bronchiale
7.1
20.1
31
46
R03BA08
ATC
ciclesonide; inhalant
3.4
19.9
76
242
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.9
19.7
45
98
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
206.5
19.7
20
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.7
19.5
65
189
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
19.4
217
1196
R95
ICPC
Chron obstructive pulmonary disease
5.3
19.1
39
77
J01MA02
ATC
ciprofloxacin; systemic
2.2
18.9
267
1613
R03AK07
ATC
formoterol and budesonide; inhalant
2.5
18.9
142
656
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
4.4
18.7
48
115
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
16.9
18.5
29
18
JN4AD
NOMESCO Finland
Body CT examination
3.1
18.5
83
292
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.9
18.3
56
153
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.6
18.3
64
192
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
68.8
17.8
20
*
A31.80
ICD-10 Finland
Oral infection caused by Mycobacterium intracellulare
+∞
17.8
17
*
A02BC02
ATC
pantoprazole; systemic
2.2
17.6
432
3195
R02
ICPC
Shortness of breath/dyspnoea
2.7
17.5
108
451
M05BA04
ATC
alendronic acid; oral
2.9
17.5
89
336
L04AX01
ATC
azathioprine; systemic
4.9
17.0
38
81
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
20.0
17.0
25
13
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
6.3
17.0
29
48
A07AA02
ATC
nystatin; oral
3.6
16.9
59
177
A03
ICPC
Fever
2.7
16.8
104
435
J01GB01
ATC
tobramycin; inhalant, parenteral
174.6
16.6
17
*
J01FA10
ATC
azithromycin; systemic
2.1
16.6
334
2271
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
4.1
16.3
47
123
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
15.9
83
317
C03CA01
ATC
furosemide; systemic
2.1
15.8
235
1423
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.2
15.7
187
1042
R03AK11
ATC
formoterol and fluticasone; inhalant
5.6
15.6
30
56
R05
ICD-10 Finland
Cough
2.3
15.3
148
757
N02AX02
ATC
tramadol; systemic, rectal
2.0
15.0
282
1848
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.4
15.0
38
90
J02AC01
ATC
fluconazole; systemic
2.0
15.0
231
1413
R01AD08
ATC
fluticasone; nasal
2.1
14.9
174
960
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
14.7
124
597
L04AA06
ATC
mycophenolic acid; systemic
14.6
14.6
24
17
JN4BD
NOMESCO Finland
Extensive body CT
2.8
14.6
81
319
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
6.0
14.6
26
45
A15.1
ICD-10 Finland
Tuberculosis of lung, confirmed by culture only
153.6
14.5
15
*
R06.0
ICD-10 Finland
Dyspnoea
2.1
14.5
191
1100
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.7
14.4
27
49
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
14.3
147
769
J01FF01
ATC
clindamycin; systemic
2.1
14.1
164
900
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
54.7
13.9
16
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
20.6
13.9
20
10
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.8
13.7
31
67
03199
ICD-8 Finland
Other diseases due to Mycobacteria, Other and unspecified
+∞
13.6
13
*
J02AC03
ATC
voriconazole; systemic
143.1
13.5
14
*
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
13.2
13.5
23
18
1240
FHL
Bronchoscopy
5.9
13.3
24
42
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
5.6
13.2
25
46
L04AD01
ATC
ciclosporin; systemic
11.3
13.1
24
22
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
19.6
13.0
19
10
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.5
12.9
46
140
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
12.8
127
652
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.9
12.7
28
59
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
12.7
148
809
127
Kela drug reimbursment
Transplant complication
15.9
12.7
20
13
ZX108
NOMESCO Finland
Inhalation
32.8
12.6
16
5
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
+∞
12.5
12
*
XQ800
NOMESCO Finland
Prick test
3.2
12.4
52
175
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.3
12.4
48
154
J01CA04
ATC
amoxicillin; systemic
2.1
12.3
473
3835
WX892
NOMESCO Finland
Monitored bed care
2.9
12.2
60
221
R05
ICPC
Cough
2.0
12.2
157
889
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
12.1
65
251
R96
ICPC
Asthma
2.7
12.1
70
281
XG466
NOMESCO Finland
Sleep oxymetry
4.0
12.0
34
88
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.5
11.8
29
67
R01AD09
ATC
mometasone; nasal
1.8
11.7
261
1770
R03DX07
ATC
roflumilast; oral
66.3
11.6
13
*
A41.8
ICD-10 Finland
Other specified sepsis
+∞
11.5
11
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
11.5
142
791
N02AA05
ATC
oxycodone; systemic
2.1
11.4
127
681
A16.0
ICD-10 Finland
Tuberculosis of lung, bacteriologically and histologically negative
35.8
11.3
14
*
348
Kela drug reimbursment
Roflumilast
35.8
11.3
14
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.5
11.1
78
344
ZXE00
NOMESCO Finland
One hour or less
1.8
11.1
239
1596
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.7
11.0
36
103
XW000
NOMESCO Finland
Bone marrow biopsy
3.8
10.9
34
94
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
15.9
10.9
17
11
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
5.3
10.9
22
43
R03BB02
ATC
oxitropium bromide; inhalant
10.8
10.8
20
19
H02AB09
ATC
hydrocortisone; systemic
5.7
10.8
20
36
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
10.8
41
130
A01AB04
ATC
amphotericin B; local oral
3.0
10.8
49
173
J20
ICD-10 Finland
Acute bronchitis
2.5
10.7
72
311
L04AA01
ATC
[U] ciclosporin
11.5
10.6
19
17
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
10.6
244
1657
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
5.6
10.5
20
37
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
10.4
133
747
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
4.8
10.3
23
49
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
19.2
10.3
15
8
SPAT1017
SPAT
Examination of colour vision
23.8
10.3
14
6
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.4
10.0
36
110
S97
ICPC
Chronic ulcer skin
3.1
9.8
42
143
R11
ICD-10 Finland
Nausea and vomiting
2.6
9.8
61
254
A01AB09
ATC
miconazole; local oral
2.4
9.7
68
299
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
9.7
87
427
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.9
9.7
45
161
M05BB03
ATC
alendronic acid and colecalciferol; oral
4.2
9.5
25
61
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
8.2
9.4
20
25
R28
ICPC
Limited function/disability (R)
7.1
9.4
22
32
R05CB01
ATC
acetylcysteine; inhalant, oral
4.8
9.4
21
45
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
37.3
9.0
11
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
9.0
68
310
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
8.1
8.9
19
24
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
8.9
69
318
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
7.3
8.8
20
28
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
8.8
68
313
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.1
8.7
24
61
B03XA02
ATC
darbepoetin alfa; parenteral
4.9
8.6
19
40
R99
ICPC
Respiratory disease other
4.9
8.6
19
40
Z2221
NOMESCO Finland
Medical doctor
1.8
8.6
163
1033
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
8.6
153
953
J01FA15
ATC
telithromycin; oral
2.4
8.5
61
271
J01DB01
ATC
cefalexin; oral
1.8
8.5
457
3835
B44.8
ICD-10 Finland
Other forms of aspergillosis
91.3
8.4
9
*
P01BA02
ATC
hydroxychloroquine; oral
2.4
8.4
57
247
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.9
8.4
40
145
TB101, ,
NOMESCO Finland
+∞
8.3
8
*
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
+∞
8.3
8
*
J15.8
ICD-10 Finland
Other bacterial pneumonia
11.0
8.3
15
14
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
8.2
73
356
ZXD05
NOMESCO Finland
Urgent procedure
1.7
8.2
173
1130
A02BC05
ATC
esomeprazole; systemic
1.7
8.2
239
1705
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.8
8.1
157
999
R29
ICPC
Respiratory symptom/complaint other
2.6
8.1
46
183
B02AA02
ATC
tranexamic acid; systemic
2.1
8.1
80
407
WZC30
NOMESCO Finland
Teaching
2.0
8.1
94
508
ZX120
NOMESCO Finland
Intravenous
2.3
8.1
61
278
R03BB07
ATC
umeclidinium bromide; inhalant
10.2
8.1
15
15
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.0
8.0
36
126
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.2
8.0
32
105
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
13.3
7.9
13
10
R4190
NOMESCO Finland
Nutritional therapy
3.6
7.9
26
75
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.1
7.9
21
52
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.3
7.8
20
48
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.3
7.8
20
48
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
7.8
45
181
Z2446
NOMESCO Finland
Social worker
2.6
7.8
45
181
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
4.0
7.8
22
57
J01XX08
ATC
linezolid; systemic
15.3
7.7
12
8
R01AD58
ATC
fluticasone, combinations; nasal
1.9
7.6
113
662
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.3
7.6
19
31
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
25.4
7.6
10
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
7.5
45
184
WW500
NOMESCO Finland
Blood transfusion
3.4
7.5
27
83
J01XB01
ATC
colistin; inhalant, parenteral
81.1
7.4
8
*
0110A
ICD-9 Finland
Pulmonary tuberculosis, Tuberculosis of lung, infiltrative[TUBERCULOSIS PULMONUM INFILTRATIVA, BAKTER.VARMA]
81.1
7.4
8
*
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.1
7.4
30
99
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.3
7.4
59
275
J01DA06
ATC
[U] cefuroxime
2.0
7.4
88
479
J01DA01
ATC
[U] cefalexin
1.6
7.4
356
2849
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.7
7.4
23
64
NF1AA
NOMESCO Finland
Hip X-ray examination
2.2
7.3
64
310
R06AE07
ATC
cetirizine; oral
1.6
7.3
226
1624
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
9.5
7.3
14
15
A07AA09
ATC
vancomycin; oral
9.5
7.3
14
15
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
+∞
7.3
7
*
B05XA03
ATC
sodium chloride; parenteral
+∞
7.3
7
*
B96.5
ICD-10 Finland
Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters
+∞
7.3
7
*
M05BX04
ATC
denosumab; parenteral
2.5
7.3
45
187
Z03.0
ICD-10 Finland
Observation for suspected tuberculosis
16.0
7.2
11
7
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.5
7.2
24
70
L04AD02
ATC
tacrolimus; systemic
20.3
7.2
10
5
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
4.1
7.1
19
47
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.2
7.1
28
91
R78
ICPC
Acute bronchitis/bronchiolitis
3.9
7.0
20
52
A02BA02
ATC
ranitidine; systemic
1.7
7.0
135
855
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.6
7.0
19
35
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
7.0
97
557
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
6.9
145
940
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.0
6.9
75
395
G04BD11
ATC
fesoterodine; oral
3.5
6.9
23
67
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.3
6.9
25
77
Z3231
NOMESCO Finland
Registered nurse
1.7
6.9
159
1059
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
4.2
6.9
18
44
A04AA01
ATC
ondansetron; systemic, rectal
2.4
6.8
48
212
L04AX03
ATC
methotrexate; systemic
2.2
6.8
55
258
A01AB10
ATC
natamycin; local oral
3.2
6.8
26
83
ZZA00
NOMESCO Finland
Split skin graft
3.6
6.8
22
63
Z94.2
ICD-10 Finland
Lung transplant status
40.5
6.8
8
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
16.9
6.8
10
6
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.5
6.8
23
68
N03AX16
ATC
[U] pregabalin
1.7
6.7
133
849
J01CF05
ATC
flucloxacillin; systemic
2.8
6.6
33
123
Z94.0
ICD-10 Finland
Kidney transplant status
12.4
6.6
11
9
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.7
6.5
20
55
R03CC02
ATC
salbutamol; systemic
3.2
6.5
25
80
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
6.5
52
243
J01CF02
ATC
cloxacillin; systemic
5.8
6.5
17
30
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
3.3
6.5
24
75
A15.2
ICD-10 Finland
Tuberculosis of lung, confirmed histologically
70.6
6.4
7
*
L01BA01
ATC
methotrexate; systemic
3.2
6.4
24
76
J04AB02
ATC
rifampicin; systemic
9.4
6.3
12
13
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
6.3
58
287
J01CE08
ATC
benzathine benzylpenicillin; parenteral
+∞
6.3
6
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
+∞
6.3
6
*
A31.8
ICD-10 Finland
Other mycobacterial infections
+∞
6.3
6
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
+∞
6.3
6
*
304
Kela drug reimbursment
Dornase alfa
+∞
6.3
6
*
XCW12, ,
SPAT
+∞
6.3
6
*
J02AC04
ATC
posaconazole; systemic
+∞
6.3
6
*
C07AB07
ATC
bisoprolol; oral
1.5
6.2
304
2402
Z3226
NOMESCO Finland
Physiotherapist
1.8
6.2
110
679
J32.4
ICD-10 Finland
Chronic pansinusitis
6.4
6.2
15
24
J33.0
ICD-10 Finland
Polyp of nasal cavity
3.5
6.2
21
62
N05CF01
ATC
zopiclone; oral
1.6
6.1
201
1454
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
12.7
6.1
10
8
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
8.7
6.1
12
14
4226
FHL
Posterior radical surgery and possible etmoidectomy
8.7
6.1
12
14
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.5
6.1
20
58
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.2
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
242
130
30.42
307.65
8.6
2.7
—
—
—
0
0
121
44
34.15
183.32
12.6
3.5
—
—
—
0
0
128
88
18.20
147.80
2.8
1.3
—
—
—
0
0
81
14
66.68
146.42
13.7
3.0
—
—
—
0
0
96
40
28.36
137.82
1.8
1.4
—
—
—
0
0
102
53
22.96
134.11
1.9
1.3
—
—
—
0
0
77
28
31.38
115.44
1.9
1.1
2.13
1.31
u/ml
0.23
58
17
83
38
25.17
114.53
1.7
1.3
—
—
—
0
0
85
42
23.39
113.72
1.7
1.4
—
—
—
0
0
69
29
26.74
98.06
1.9
1.4
—
—
—
0
0
84
60
16.10
93.88
1.3
1.1
—
—
—
0
0
160
286
7.25
90.78
3.1
2.4
10.41
10.75
g/l
0.31
153
253
80
0
+∞
85.49
2.6
0.0
—
—
—
0
0
88
80
12.71
85.10
2.3
1.3
—
—
—
0
0
85
77
12.69
82.32
2.3
1.3
—
—
—
0
0
133
219
7.51
81.00
1.8
1.6
1.40
1.74
g/l
0.43
121
197
73
55
14.96
78.91
2.3
1.3
—
—
—
0
0
129
237
6.65
70.25
2.0
1.2
149.08
287.51
u/ml
0.71
121
220
48
22
23.62
65.53
2.8
1.8
1729.75
492.45
e6/l
0.67
48
22
219
700
4.34
61.77
3.0
1.7
—
—
—
0
0
53
36
16.04
60.33
2.3
1.3
—
—
—
0
0
42
18
25.01
58.73
1.6
1.0
—
—
—
0
0
52
46
12.28
50.64
2.2
1.2
—
—
—
0
0
53
54
10.66
46.92
2.5
1.4
—
—
—
0
0
53
54
10.66
46.92
2.5
1.4
—
—
—
0
0
433
2554
3.47
42.70
19.5
7.2
4.73
4.03
e9/l
6.16
416
2224
109
266
4.78
42.36
1.9
1.5
—
—
—
0
0
61
85
7.87
42.28
1.9
1.4
—
—
—
0
0
36
26
14.66
39.37
1.9
1.1
—
—
—
0
0
145
489
3.59
35.78
2.5
1.7
—
—
—
0
0
179
695
3.24
35.17
7.3
2.7
0.82
0.82
mmol/l
0.21
170
649
48
66
7.82
33.53
5.3
2.7
5.26
4.03
e9/l
1.91
48
66
141
489
3.46
33.11
2.6
1.7
—
—
—
0
0
97
260
4.25
33.09
6.0
3.0
1.84
2.07
mmol/l
0.21
75
195
60
109
6.00
32.26
1.9
1.5
0.29
0.18
iu/ml
0.21
14
18
48
71
7.26
31.43
5.4
2.8
61.98
56.58
%
1.93
48
71
35
35
10.55
31.20
2.3
1.6
—
—
—
0
0
187
794
2.96
30.94
1.7
1.4
2.58
2.45
g/l
0.39
134
432
40
13
32.84
30.75
1.8
1.1
—
—
—
0
0
38
11
36.75
30.00
1.9
1.1
—
—
—
0
0
38
11
36.75
30.00
1.9
1.1
—
—
—
0
0
35
38
9.72
29.41
2.3
1.5
—
—
—
0
0
38
14
28.86
28.33
3.2
2.5
—
—
—
0
0
383
2411
2.61
27.98
14.0
4.9
8.89
11.02
umol/l
12.16
375
2266
55
107
5.56
27.44
5.2
2.5
24.92
25.69
mmol/l
0.55
55
107
31
33
9.85
26.39
2.0
1.4
—
—
—
0
0
31
33
9.85
26.39
2.0
1.4
—
—
—
0
0
31
33
9.85
26.39
2.0
1.4
—
—
—
0
0
372
2393
2.45
24.64
13.0
5.3
1.21
1.22
mmol/l
0.93
308
2011
29
6
50.63
24.49
1.5
1.2
—
—
—
0
0
69
180
4.20
24.18
3.6
1.6
—
—
—
0
0
64
164
4.25
22.94
2.9
1.5
—
—
—
0
0
342
2176
2.32
22.42
11.1
4.8
1.22
1.22
mmol/l
0.02
325
1940
117
466
2.87
21.01
6.6
3.7
243.01
238.11
u/l
0.14
111
428
41
80
5.43
20.33
2.8
2.0
15.19
16.47
%
0.91
25
42
26
33
8.19
19.28
1.2
1.0
—
—
—
0
0
27
36
7.80
19.23
3.1
1.5
—
—
—
0
0
27
36
7.80
19.23
3.1
1.5
—
—
—
0
0
43
92
4.96
19.22
2.4
1.8
121.06
130.37
g/l
1.24
31
65
24
7
35.62
19.02
1.3
1.1
—
—
—
0
0
46
106
4.62
18.82
5.0
2.5
7.93
8.32
kpa
0.83
46
106
41
86
5.04
18.74
1.7
1.2
—
—
—
0
0
41
86
5.04
18.74
1.7
1.2
—
—
—
0
0
456
3459
2.31
17.29
11.4
3.8
18.79
11.99
mm/h
12.58
444
3127
310
2051
2.05
16.58
7.3
3.9
33.02
35.84
g/l
11.96
288
1894
34
69
5.16
16.12
2.6
1.5
—
—
—
0
0
26
18
15.04
15.97
2.0
1.2
—
—
—
0
0
26
18
15.04
15.97
2.0
1.2
—
—
—
0
0
94
384
2.72
15.86
1.7
2.6
64.48
66.70
g/l
1.65
82
339
136
663
2.36
15.80
3.6
2.1
11.11
12.81
umol/l
2.11
129
604
201
1158
2.10
15.42
2.8
2.1
3.31
3.10
mg/l
0.52
180
950
120
570
2.38
14.70
3.9
2.1
18.57
22.40
%
3.13
104
478
71
260
2.96
14.65
2.3
1.6
—
—
—
0
0
21
11
19.72
14.32
2.2
1.4
—
—
—
0
0
21
11
19.72
14.32
2.1
1.4
—
—
—
0
0
21
11
19.72
14.32
2.1
1.4
—
—
—
0
0
122
595
2.32
14.03
3.8
2.1
2.20
2.32
g/l
1.55
113
542
27
51
5.50
13.83
1.3
1.3
112.55
106.75
u/ml
—
11
8
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
44
128
3.63
13.16
4.1
2.7
0.40
0.39
u/ml
0.04
27
78
274
1839
1.90
13.07
3.7
2.6
132.90
119.37
ug/l
0.57
259
1642
321
2268
1.89
13.04
22.4
14.0
1.26
1.28
inr
0.13
117
630
113
553
2.28
12.81
13.3
3.8
1.05
1.04
mmol/l
0.28
106
492
105
502
2.32
12.56
3.4
2.1
1.89
1.74
%
0.62
93
434
86
386
2.43
11.83
2.0
1.8
302.71
374.07
nmol/l
2.73
79
347
80
348
2.50
11.77
17.9
5.0
10.08
9.69
mmol/l
0.20
75
327
23
25
9.52
11.58
4.3
2.7
37.96
39.91
%
0.09
11
16
34
91
3.90
11.45
1.4
1.3
—
—
—
0
0
329
2410
1.80
11.27
3.2
2.6
—
—
—
0
0
448
3611
1.94
11.22
19.6
6.2
81.53
77.21
u/l
1.15
442
3343
18
14
13.21
10.70
1.9
2.4
783.39
613.36
u/ml
0.24
18
14
35
101
3.62
10.60
4.4
2.2
95.43
89.33
%
0.64
35
95
24
53
4.67
10.32
1.3
1.2
—
—
—
0
0
224
1494
1.79
10.28
4.2
2.9
1506.76
1340.83
ng/l
0.22
205
1268
356
2714
1.76
10.23
8.7
4.0
6.43
6.63
mmol/l
1.43
346
2528
33
94
3.66
10.18
1.2
1.1
—
—
—
0
0
24
55
4.50
9.88
1.6
1.3
—
—
—
0
0
99
508
2.14
9.86
9.4
6.5
1.54
1.18
mmol/l
0.33
85
403
13
5
26.51
9.84
1.1
1.0
92.77
100.20
%
—
13
5
83
402
2.23
9.53
8.5
2.6
2.66
2.09
mmol/l
0.63
74
332
151
910
1.88
9.52
3.0
1.6
1.72
1.27
mg/l
0.39
124
699
22
32
7.09
9.39
1.5
1.2
51.77
42.58
u/l
0.60
22
26
47
178
2.78
9.10
2.0
2.3
—
—
—
0
0
41
144
2.98
9.09
1.8
3.8
183.91
94.88
mg/l
0.33
31
115
126
727
1.93
9.02
1.3
1.3
78.34
39.83
iu/ml
0.71
48
231
41
145
2.96
8.98
1.7
3.8
42.64
40.04
mg/l
0.06
32
118
22
51
4.44
8.93
1.3
1.2
410.48
251.96
u/ml
0.77
16
24
199
1327
1.75
8.88
6.2
2.9
0.19
0.43
e6/l
2.51
173
1010
54
223
2.56
8.83
1.6
1.3
—
—
—
0
0
210
1427
1.72
8.74
6.2
3.0
16.22
114.84
e6/l
1.43
183
1104
12
6
20.36
8.50
2.7
1.2
—
—
—
0
0
47
186
2.66
8.37
2.2
1.8
1.60
1.55
g/l
0.16
39
156
234
1661
1.67
8.15
5.0
3.1
2.34
2.36
mmol/l
1.76
212
1432
22
58
3.90
7.59
1.7
1.3
—
—
—
0
0
19
45
4.33
7.52
1.1
1.0
1.48
1.52
g/l
0.17
19
38
22
59
3.83
7.41
1.7
1.3
—
—
—
0
0
22
59
3.83
7.41
1.7
1.3
—
—
—
0
0
35
128
2.84
7.25
1.5
1.1
—
—
—
0
0
200
1401
1.64
7.14
5.2
2.7
33.40
33.01
u/l
0.03
194
1327
39
153
2.66
7.08
1.9
2.7
0.76
1.00
g/l
0.20
33
129
41
167
2.56
6.92
2.0
2.4
9.94
10.44
g/l
0.32
36
142
230
1685
1.59
6.75
6.2
2.9
—
—
—
0
0
258
1942
1.57
6.74
2.9
2.1
81.53
79.25
nmol/l
0.67
234
1673
21
59
3.65
6.64
1.8
1.3
—
—
—
0
0
21
59
3.65
6.64
1.8
1.3
—
—
—
0
0
17
41
4.24
6.59
4.8
2.3
—
—
—
0
0
21
60
3.59
6.49
1.8
1.3
—
—
—
0
0
168
1151
1.64
6.45
6.9
3.2
91.45
89.58
%
0.43
163
1121
83
464
1.91
6.44
5.7
3.0
—
—
—
0
0
201
1446
1.59
6.29
3.2
2.1
60.24
117.84
u/l
0.51
189
1320
14
22
6.49
5.89
12.7
6.7
51.14
60.50
u/ml
—
7
6
73
405
1.91
5.79
3.4
3.0
139.85
199.24
ng/l
1.44
67
365
243
1851
1.52
5.78
5.8
3.4
76.86
60.20
ng/l
0.17
190
1358
17
46
3.77
5.68
2.2
1.3
58.42
63.60
%
0.18
12
30
9
7
13.03
5.59
1.2
1.1
—
—
—
0
0
26
98
2.73
5.14
1.7
1.2
—
—
—
0
0
12
19
6.42
5.10
1.8
1.2
49.00
13.08
u/l
0.76
12
13
138
954
1.58
4.97
1.8
1.8
1372.55
1172.56
nmol/l
1.57
102
687
11
16
6.98
4.97
1.6
1.3
—
—
—
0
0
11
16
6.98
4.97
1.6
1.3
—
—
—
0
0
64
360
1.87
4.88
4.9
2.8
77.70
75.61
ng/l
0.08
59
313
167
1211
1.52
4.85
1.6
1.5
19.28
20.97
nmol/l
0.84
145
995
152
1095
1.52
4.51
5.0
2.5
7277.63
9084.80
umol/l
0.13
142
915
11
19
5.87
4.46
1.6
1.4
—
—
—
0
0
11
19
5.87
4.46
1.9
1.2
149.55
73.86
u/l
1.09
11
14
117
802
1.57
4.34
4.9
2.6
0.58
1.05
e6/l
2.43
79
470
10
16
6.33
4.31
4.7
1.6
24.30
30.00
umol/l
—
10
16
422
4666
0.68
4.28
5.4
5.2
2.59
2.70
mmol/l
1.80
382
4210
69
415
1.75
4.24
2.4
2.1
30.75
32.29
u/l
0.18
60
354
32
147
2.24
4.22
1.7
2.4
33.51
37.90
g/l
2.14
27
122
149
1095
1.48
3.97
3.8
2.2
—
—
—
0
0
76
479
1.67
3.95
2.7
2.1
6.06
6.86
umol/l
0.28
69
413
12
27
4.51
3.95
1.0
1.1
—
—
—
0
0
8
11
7.35
3.87
1.8
1.1
0.40
3.17
mmol/l
—
8
11
10
19
5.33
3.84
1.7
1.4
—
—
—
0
0
102
697
1.56
3.82
1.2
1.3
20.38
12.34
u/ml
0.33
30
269
251
2047
1.39
3.72
2.0
2.0
94.05
95.69
pmol/l
0.24
151
1008
24
103
2.39
3.71
2.0
1.6
—
—
—
0
0
13
34
3.88
3.71
1.3
1.1
—
—
—
0
0
28
129
2.23
3.69
1.5
1.3
242.63
301.94
ug/g
0.80
16
70
414
4554
0.71
3.59
5.0
4.5
4.55
4.61
mmol/l
0.60
371
4126
412
4522
0.72
3.38
4.9
4.5
1.58
1.49
mmol/l
3.05
371
4070
127
938
1.45
3.26
1.2
1.3
1.07
1.42
u/ml
0.45
25
231
82
553
1.56
3.25
17.0
5.6
103.34
104.38
mmol/l
1.09
82
553
16
60
2.71
3.25
4.1
2.1
27.00
25.79
mg/l
—
6
18
22
99
2.27
3.09
2.2
2.5
162.48
92.96
ug/min
0.46
13
57
15
56
2.72
3.08
1.1
1.1
—
—
—
0
0
416
4539
0.73
3.07
5.3
4.8
5.84
5.97
mmol/l
1.31
379
4031
7
12
5.89
3.03
1.3
1.3
—
—
—
0
0
130
979
1.42
2.99
3.2
2.8
2.49
2.45
mmol/l
2.44
115
861
5
5
10.07
2.98
1.2
1.2
—
—
—
0
0
5
5
10.07
2.98
1.0
1.0
—
—
—
0
0
27
135
2.05
2.95
2.4
1.9
—
—
—
0
0
14
52
2.73
2.90
1.6
1.2
1.40
1.50
u/ml
—
5
16
10
27
3.75
2.89
1.3
1.0
—
—
—
0
0
11
34
3.28
2.74
1.6
1.3
—
—
—
0
0
16
66
2.46
2.73
1.1
1.1
—
—
—
0
0
102
749
1.44
2.69
5.8
2.8
2.28
2.47
e6/l
0.07
65
422
319
2791
1.30
2.66
6.3
2.8
50.75
46.31
u/l
0.46
303
2557
122
927
1.40
2.65
4.8
3.6
946.76
291.79
ng/l
0.63
98
753
8
20
4.04
2.57
2.0
1.5
—
—
—
0
0
21
101
2.12
2.56
2.0
1.3
—
—
—
0
0
13
50
2.64
2.54
1.5
1.1
—
—
—
0
0
179
1458
1.32
2.48
3.2
2.0
115.89
206.38
u/l
2.69
171
1348
401
4347
0.77
2.36
4.4
4.0
1.14
1.26
mmol/l
3.61
355
3878
10
33
3.06
2.36
1.3
2.1
—
—
—
0
0
11
39
2.85
2.35
2.8
2.8
—
—
—
0
0
19
91
2.12
2.35
1.3
1.2
—
—
—
0
0
10
34
2.97
2.29
1.4
1.2
—
—
—
0
0
10
34
2.97
2.29
1.4
1.2
—
—
—
0
0
131
1036
1.34
2.21
1.7
1.7
466.28
7220667.55
pmol/l
0.50
109
831
24
129
1.90
2.20
2.0
1.6
—
—
—
0
0
7
20
3.53
2.06
1.3
1.3
—
—
—
0
0
246
2142
1.25
1.94
3.9
2.4
—
—
—
0
0
6
16
3.78
1.94
1.2
1.2
—
—
—
0
0
61
435
1.45
1.91
3.1
2.4
8.88
7.23
ug/l
0.33
49
374
485
4571
1.31
1.90
42.2
12.1
22.71
22.75
mg/l
0.01
457
3518
32
199
1.64
1.84
1.7
1.3
—
—
—
0
0
53
372
1.47
1.81
3.8
2.4
71.54
63.86
ml/min/173m2
0.84
28
153
13
60
2.19
1.79
4.0
1.8
31.54
32.18
pg
0.23
13
60
9
36
2.52
1.74
1.4
1.3
—
—
—
0
0
408
4355
0.80
1.70
6.1
5.9
39.45
39.90
mmol/mol
0.50
379
3962
256
2268
1.22
1.66
6.0
3.8
0.00
0.01
estimate
0.50
78
409
10
41
2.46
1.65
4.0
2.1
—
—
—
0
0
20
113
1.80
1.62
1.3
1.2
—
—
—
0
0
253
2248
1.22
1.57
8.0
5.0
0.00
0.00
estimate
-0.00
79
416
252
2239
1.22
1.57
6.0
3.8
0.00
0.00
estimate
0.50
77
450
10
44
2.29
1.56
1.5
1.6
—
—
—
0
0
33
217
1.55
1.55
4.1
2.7
26.26
25.42
mmol/l
0.53
33
211
6
21
2.88
1.51
2.7
2.9
—
—
—
0
0
40
277
1.48
1.49
7.4
6.3
25.59
24.67
mmol/l
0.67
40
262
23
141
1.66
1.43
1.4
1.2
—
—
—
0
0
78
612
1.32
1.41
1.5
1.4
—
—
—
0
0
23
142
1.64
1.40
1.4
1.2
—
—
—
0
0
103
1240
0.80
1.32
4.5
4.6
21.01
21.16
%
0.03
50
623
48
639
0.73
1.30
13.1
6.6
—
—
—
0
0
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
6
25
2.41
1.24
1.5
1.4
—
—
—
0
0
6
25
2.41
1.24
1.5
1.4
—
—
—
0
0
84
1028
0.79
1.24
6.3
4.1
1.02
1.02
kg/l
0.22
21
150
7
30
2.35
1.12
1.6
1.5
61.00
78.63
umol/l
—
7
30
374
3512
1.17
1.10
4.4
3.9
15.10
14.89
pmol/l
0.80
340
3124
7
32
2.20
1.08
1.3
1.0
—
—
—
0
0
16
98
1.65
1.04
1.9
1.2
—
—
—
0
0
490
5065
0.83
1.03
53.8
19.1
4.32
4.47
e12/l
9.16
483
4900
7
34
2.07
1.03
1.0
1.1
—
—
—
0
0
7
34
2.07
1.03
1.0
1.1
—
—
—
0
0
29
205
1.44
1.03
13.9
2.0
0.64
0.67
%
0.18
29
205
490
5063
0.83
1.01
53.9
19.1
266.17
245.18
e9/l
7.84
485
4913
490
5063
0.83
1.01
55.1
19.1
39.09
39.96
%
2.75
467
4693
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
132
1508
0.84
1.00
4.1
3.0
5.88
7.24
mmol/l
4.66
122
1245
134
1527
0.84
0.98
5.1
3.6
14.56
7.72
mg/mmol
0.80
100
919
5
23
2.18
0.98
1.0
1.0
326.80
259.00
mg/l
—
5
17
29
213
1.38
0.86
13.9
2.0
1.00
1.23
%
0.88
29
213
141
1253
1.16
0.83
6.9
4.0
0.00
0.00
estimate
0.50
73
406
36
277
1.32
0.81
13.1
2.4
126.58
128.79
g/l
0.25
36
271
17
116
1.48
0.75
1.1
1.3
—
—
—
0
0
5
24
2.09
0.74
4.6
3.7
1038.20
135.29
nmol/l
—
5
24
13
84
1.56
0.72
1.2
1.5
233.80
285.00
miu/ml
—
5
36
132
1453
0.88
0.61
4.3
3.1
1370.82
227.41
mg/l
1.08
101
893
23
298
0.76
0.59
1.5
1.7
—
—
—
0
0
0
23
0.00
0.58
0.0
2.1
—
45.70
—
0
18
142
1548
0.89
0.56
5.5
5.3
2.77
2.82
ug/l
0.03
124
1363
6
37
1.63
0.55
1.0
1.0
—
—
—
0
0
9
65
1.39
0.50
1.2
1.6
—
—
—
0
0
7
45
1.56
0.49
1.1
1.0
—
—
—
0
0
7
48
1.46
0.47
1.1
1.0
—
—
—
0
0
7
50
1.40
0.45
1.3
1.2
—
—
—
0
0
7
50
1.40
0.45
2.3
1.4
—
—
—
0
0
138
1278
1.10
0.44
1.7
1.6
1.22
1.33
mmol/l
1.06
116
1054
8
57
1.41
0.42
1.0
1.0
—
—
—
0
0
7
103
0.68
0.40
1.4
1.4
—
—
—
0
0
82
896
0.90
0.36
3.4
3.2
0.84
0.79
ug/l
0.10
62
600
6
47
1.28
0.32
5.5
3.1
5.47
6.87
nmol/l
—
6
47
7
55
1.28
0.30
1.6
2.0
4.69
5.99
u/ml
—
7
55
445
4369
1.07
0.29
30.9
12.3
77.45
76.68
ml/min/173m2
0.31
410
3586
9
119
0.75
0.27
1.8
1.7
—
—
—
0
0
29
253
1.15
0.26
1.4
1.4
—
46.88
—
0
21
6
84
0.71
0.24
1.7
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
0.86
—
0
5
0
10
0.00
0.21
0.0
1.7
—
7.35
—
0
10
6
49
1.23
0.20
5.7
2.8
29.55
61.27
u/ml
—
6
49
485
4900
0.95
0.18
25.3
9.5
23.10
24.76
u/l
2.14
480
4667
432
4264
1.05
0.18
5.4
4.7
1.87
2.27
mu/l
0.76
399
3807
24
214
1.13
0.17
1.0
1.1
—
—
—
0
0
67
631
1.07
0.17
4.3
4.7
35.89
32.26
%
1.77
53
391
26
286
0.90
0.15
2.3
2.0
—
—
—
0
0
12
102
1.18
0.15
1.7
1.7
—
—
—
0
0
56
594
0.94
0.15
1.5
1.4
—
—
—
0
0
25
267
0.93
0.08
1.1
1.2
53.24
120.27
iu/ml
1.34
14
102
20
215
0.93
0.07
6.2
3.0
37.75
50.79
u/ml
0.30
20
207
10
108
0.92
0.03
1.6
1.8
48.80
41.72
nmol/l
—
10
103
25
257
0.97
0.01
2.3
1.9
—
—
—
0
0
175
1756
1.00
0.00
6.8
3.9
—
—
—
0
0
13
127
1.02
0.00
1.6
1.8
—
—
—
0
0
39
385
1.01
0.00
1.5
1.7
1.59
1.51
%
0.41
34
333
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
7
79
0.88
0.00
1.4
1.9
160.57
227.58
pmol/l
—
7
74
0
6
0.00
0.00
0.0
2.3
—
1.17
—
0
6
0
8
0.00
0.00
0.0
1.1
—
15.94
—
0
8
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
0.40
—
0
5
6
62
0.97
-0.00
3.3
2.0
106.17
105.76
mmol/l
—
6
62
0
5
0.00
-0.00
0.0
1.0
—
30.74
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_OTHER_MYCOBAC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_MYCOBAC | 1.906 [1.65, 2.2] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.125 |
During the follow-up period (1.1.1998 — 31.12.2019), 658 out of 1676 females with AB1_OTHER_MYCOBAC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_MYCOBAC | 2.693 [2.15, 3.37] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 619 out of 1250 males with AB1_OTHER_MYCOBAC died.
Mortality risk
Mortality risk for people of age
years, who have AB1_OTHER_MYCOBAC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.197% | 0.472% |
| 5 | 1.066% | 2.948% |
| 10 | 2.455% | 6.89% |
| 15 | 4.73% | 12.749% |
| 20 | 8.37% | 21.26% |
Relationships between endpoints
↥Index endpoint: AB1_OTHER_MYCOBAC – Infection due to other mycobacteria
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data